Ingestion of more than 3 grams of Omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding diathesis.
There is currently no manufacturer warning information available for this drug.
VP-HEME One is a prescription multivitamin/ multimineral nutritional supplement with Omega-3 fatty acid indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. VP-HEME One is also beneficial in improving the nutritional status of women prior to conception.
DESCRIPTION: VP-HEME One is a prescription prenatal/postnatal multivitamin/ multimineral nutritional supplement with Omega-3 fatty acid. VP-HEME One is an oblong shaped, opaque purple colored softgel, imprinted with V240 in white ink on one side and plain on the other.
|
|
| Each VP-HEME One Softgel contains: | |
| Vitamin C (as ascorbic acid) | 25 mg |
| Vitamin D3 (as cholecalciferol) | 400 IU |
| Vitamin E (as dl-alpha tocopheryl acetate) | 10 IU |
| Vitamin B3 (niacin as niacinamide) | 17 mg |
| Vitamin B6 (as pyridoxine HCI) | 50 mg |
| Folic Acid | 1 mg |
| Vitamin B12 (as cyanocobalamin) | 12 mcg |
| Biotin | 30 mcg |
| Vitamin B5 (as d-calcium pantothenate) | 10 mg |
| Iron as Polysaccharide Iron Complex |
22 mg |
| as heme iron | 6 mg |
| Iodine (as potassium iodide) | 175 mcg |
| Zinc (as zinc oxide) | 15 mg |
| Docosahexaenoic Acid (DHA) | 200 mg* |